2017 Fiscal Year Final Research Report
New therapy for hepatocellular carcinoma
| Project/Area Number |
15K08999
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Okayama University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
桑木 健志 岡山大学, 大学病院, 助教 (80643387)
大西 秀樹 岡山大学, 大学病院, 助教 (30595468)
中村 進一郎 岡山大学, 大学病院, 講師 (70514230)
能祖 一裕 岡山大学, 医学部, 客員研究員 (10314668)
岩室 雅也 岡山大学, 大学病院, 助教 (30645403)
堀口 繁 岡山大学, 大学病院, 助教 (70761104)
竹内 康人 岡山大学, 大学病院, 助教 (70814200)
|
|---|
| Project Period (FY) |
2015-04-01 – 2018-03-31
|
| Keywords | 肝細胞癌 / Notch シグナル / 上皮間葉転換 |
|---|
| Outline of Final Research Achievements |
Cytotoxic agents have been developed to treat advanced hepatocellular carcinoma (HCC). Notch signaling is associated with carcinogenesis, epithelial-mesenchymal-transition (EMT), cancer stem cells (CSC). We investigated the effect of gamma-secretase inhibitor (GSI), a Notch inhibitor, in combination with cytotoxic agents in HCC cell lines. GSI exerts an anti-tumor effect via inhibition of EMT and CSC, consequently enhancing cell sensitivity to cytotoxic agents.
|
| Free Research Field |
消化器内科
|
